Dysmenorrhea in Adolescents

Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities su...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the New York Academy of Sciences 2008-06, Vol.1135 (1), p.185-195
1. Verfasser: Harel, Zeev
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 195
container_issue 1
container_start_page 185
container_title Annals of the New York Academy of Sciences
container_volume 1135
creator Harel, Zeev
description Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found. Potent prostaglandins and leukotrienes play an important role in generating the symptoms of dysmenorrhea. Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most common pharmacologic treatment for dysmenorrhea. A loading dose of NSAIDs (typically twice the regular dose) should be used as initial treatment for dysmenorrhea in adolescents, followed by a regular dose until symptoms abate. Adolescents with symptoms that do not respond to treatment with NSAIDs for three menstrual periods should be offered hormonal treatment such as combined estrogen/progestin oral contraceptive pills for three menstrual cycles. Adolescents with dysmenorrhea who do not respond to this treatment should be evaluated for secondary causes of dysmenorrhea. The adolescent care provider's role is to explain the pathophysiology of dysmenorrhea to every adolescent female, address any concern that the patient has about her menstrual period, and review effective treatment options for dysmenorrhea with the patient.
doi_str_mv 10.1196/annals.1429.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69239961</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69239961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4737-cfa385e767b7f3182b381d921ad8db2c27fb0e044ea83833dd0056e09144c3433</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotlbPHgTpydu2mSSbj2OpWoVakdaKp5DdzeLqftSkRfvvTdmiR08Dw_M-zLwInQMeACg-NHVtSj8ARtQAY3GAuiCYijin5BB1w0ZEUhHaQSfev2MMRDJxjDogY8EIYV10cb31la0b596s6Rd1f5Q1pfWprdf-FB3lwW7P9rOHnm9vFuO7aPo4uR-PplHKBBVRmhsqYyu4SEROQZKESsgUAZPJLCEpEXmCLWbMGkklpVmGccwtVsBYShmlPXTVeleu-dxYv9ZVES4oS1PbZuM1Dx8oxSGAwxZMXeO9s7leuaIybqsB610fuu1D7_rQ4fuQuNyrN0llsz9-X0AAZAt8FaXd_ufTs9fRHIDGrTtqo4Vf2-_fqHEfmodeYv0ym2i2nD4s5vCkl_QHgVN7gA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69239961</pqid></control><display><type>article</type><title>Dysmenorrhea in Adolescents</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Harel, Zeev</creator><creatorcontrib>Harel, Zeev</creatorcontrib><description>Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found. Potent prostaglandins and leukotrienes play an important role in generating the symptoms of dysmenorrhea. Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most common pharmacologic treatment for dysmenorrhea. A loading dose of NSAIDs (typically twice the regular dose) should be used as initial treatment for dysmenorrhea in adolescents, followed by a regular dose until symptoms abate. Adolescents with symptoms that do not respond to treatment with NSAIDs for three menstrual periods should be offered hormonal treatment such as combined estrogen/progestin oral contraceptive pills for three menstrual cycles. Adolescents with dysmenorrhea who do not respond to this treatment should be evaluated for secondary causes of dysmenorrhea. The adolescent care provider's role is to explain the pathophysiology of dysmenorrhea to every adolescent female, address any concern that the patient has about her menstrual period, and review effective treatment options for dysmenorrhea with the patient.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1196/annals.1429.007</identifier><identifier>PMID: 18574224</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adolescent ; adolescents ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Contraceptives, Oral, Combined - therapeutic use ; Contraceptives, Oral, Hormonal - therapeutic use ; dysmenorrhea ; Dysmenorrhea - diagnosis ; Dysmenorrhea - epidemiology ; Dysmenorrhea - etiology ; Dysmenorrhea - physiopathology ; Dysmenorrhea - therapy ; Estrogens - therapeutic use ; Female ; Humans ; Menstrual Cycle - physiology ; Prevalence ; Progesterone Congeners - therapeutic use ; Risk Factors ; secondary dysmenorrhea</subject><ispartof>Annals of the New York Academy of Sciences, 2008-06, Vol.1135 (1), p.185-195</ispartof><rights>2008 New York Academy of Sciences</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4737-cfa385e767b7f3182b381d921ad8db2c27fb0e044ea83833dd0056e09144c3433</citedby><cites>FETCH-LOGICAL-c4737-cfa385e767b7f3182b381d921ad8db2c27fb0e044ea83833dd0056e09144c3433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1196%2Fannals.1429.007$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1196%2Fannals.1429.007$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18574224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harel, Zeev</creatorcontrib><title>Dysmenorrhea in Adolescents</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found. Potent prostaglandins and leukotrienes play an important role in generating the symptoms of dysmenorrhea. Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most common pharmacologic treatment for dysmenorrhea. A loading dose of NSAIDs (typically twice the regular dose) should be used as initial treatment for dysmenorrhea in adolescents, followed by a regular dose until symptoms abate. Adolescents with symptoms that do not respond to treatment with NSAIDs for three menstrual periods should be offered hormonal treatment such as combined estrogen/progestin oral contraceptive pills for three menstrual cycles. Adolescents with dysmenorrhea who do not respond to this treatment should be evaluated for secondary causes of dysmenorrhea. The adolescent care provider's role is to explain the pathophysiology of dysmenorrhea to every adolescent female, address any concern that the patient has about her menstrual period, and review effective treatment options for dysmenorrhea with the patient.</description><subject>Adolescent</subject><subject>adolescents</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Contraceptives, Oral, Combined - therapeutic use</subject><subject>Contraceptives, Oral, Hormonal - therapeutic use</subject><subject>dysmenorrhea</subject><subject>Dysmenorrhea - diagnosis</subject><subject>Dysmenorrhea - epidemiology</subject><subject>Dysmenorrhea - etiology</subject><subject>Dysmenorrhea - physiopathology</subject><subject>Dysmenorrhea - therapy</subject><subject>Estrogens - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Menstrual Cycle - physiology</subject><subject>Prevalence</subject><subject>Progesterone Congeners - therapeutic use</subject><subject>Risk Factors</subject><subject>secondary dysmenorrhea</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotlbPHgTpydu2mSSbj2OpWoVakdaKp5DdzeLqftSkRfvvTdmiR08Dw_M-zLwInQMeACg-NHVtSj8ARtQAY3GAuiCYijin5BB1w0ZEUhHaQSfev2MMRDJxjDogY8EIYV10cb31la0b596s6Rd1f5Q1pfWprdf-FB3lwW7P9rOHnm9vFuO7aPo4uR-PplHKBBVRmhsqYyu4SEROQZKESsgUAZPJLCEpEXmCLWbMGkklpVmGccwtVsBYShmlPXTVeleu-dxYv9ZVES4oS1PbZuM1Dx8oxSGAwxZMXeO9s7leuaIybqsB610fuu1D7_rQ4fuQuNyrN0llsz9-X0AAZAt8FaXd_ufTs9fRHIDGrTtqo4Vf2-_fqHEfmodeYv0ym2i2nD4s5vCkl_QHgVN7gA</recordid><startdate>200806</startdate><enddate>200806</enddate><creator>Harel, Zeev</creator><general>Blackwell Publishing Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200806</creationdate><title>Dysmenorrhea in Adolescents</title><author>Harel, Zeev</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4737-cfa385e767b7f3182b381d921ad8db2c27fb0e044ea83833dd0056e09144c3433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>adolescents</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Contraceptives, Oral, Combined - therapeutic use</topic><topic>Contraceptives, Oral, Hormonal - therapeutic use</topic><topic>dysmenorrhea</topic><topic>Dysmenorrhea - diagnosis</topic><topic>Dysmenorrhea - epidemiology</topic><topic>Dysmenorrhea - etiology</topic><topic>Dysmenorrhea - physiopathology</topic><topic>Dysmenorrhea - therapy</topic><topic>Estrogens - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Menstrual Cycle - physiology</topic><topic>Prevalence</topic><topic>Progesterone Congeners - therapeutic use</topic><topic>Risk Factors</topic><topic>secondary dysmenorrhea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harel, Zeev</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harel, Zeev</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dysmenorrhea in Adolescents</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>2008-06</date><risdate>2008</risdate><volume>1135</volume><issue>1</issue><spage>185</spage><epage>195</epage><pages>185-195</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found. Potent prostaglandins and leukotrienes play an important role in generating the symptoms of dysmenorrhea. Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most common pharmacologic treatment for dysmenorrhea. A loading dose of NSAIDs (typically twice the regular dose) should be used as initial treatment for dysmenorrhea in adolescents, followed by a regular dose until symptoms abate. Adolescents with symptoms that do not respond to treatment with NSAIDs for three menstrual periods should be offered hormonal treatment such as combined estrogen/progestin oral contraceptive pills for three menstrual cycles. Adolescents with dysmenorrhea who do not respond to this treatment should be evaluated for secondary causes of dysmenorrhea. The adolescent care provider's role is to explain the pathophysiology of dysmenorrhea to every adolescent female, address any concern that the patient has about her menstrual period, and review effective treatment options for dysmenorrhea with the patient.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>18574224</pmid><doi>10.1196/annals.1429.007</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0077-8923
ispartof Annals of the New York Academy of Sciences, 2008-06, Vol.1135 (1), p.185-195
issn 0077-8923
1749-6632
language eng
recordid cdi_proquest_miscellaneous_69239961
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
adolescents
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Contraceptives, Oral, Combined - therapeutic use
Contraceptives, Oral, Hormonal - therapeutic use
dysmenorrhea
Dysmenorrhea - diagnosis
Dysmenorrhea - epidemiology
Dysmenorrhea - etiology
Dysmenorrhea - physiopathology
Dysmenorrhea - therapy
Estrogens - therapeutic use
Female
Humans
Menstrual Cycle - physiology
Prevalence
Progesterone Congeners - therapeutic use
Risk Factors
secondary dysmenorrhea
title Dysmenorrhea in Adolescents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T13%3A27%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dysmenorrhea%20in%20Adolescents&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Harel,%20Zeev&rft.date=2008-06&rft.volume=1135&rft.issue=1&rft.spage=185&rft.epage=195&rft.pages=185-195&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1196/annals.1429.007&rft_dat=%3Cproquest_cross%3E69239961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69239961&rft_id=info:pmid/18574224&rfr_iscdi=true